Effect of losartan on high-sensitivity C-reactive protein and insulin resistance in esstential hypertensive patients

Chen Gailing,Hei yan,Wang Yong,Zhang hu,Jiang hong,Wang Y

DOI: https://doi.org/10.16563/j.cnki.1671-6272.2011.06.007

2011-01-01

Abstract:Objective To investigate the effect of losartan on serum high-sensitivity C-reactive protein (hs-CRP)and insulin resistance in hypertensive patients. Methods After two weeks of single blind placebo period ,51 hypertensive patients were divided into experimental group (losartan 50 mg , once per day) and control group(nifidipine 10mg twice per day)for eight weeks for both groups. The level of fasting blood glucose ( FBG) , fasting insulin ( FINS) , HOMA-IR and hs-CRP were evaluated before and the end of treatment. Results SBP and DBP were significantly reduced in two groups after treatment ( P < 0. 001) .The level of hs-CRP ,FINS and HOMA-IR were significantly decreased in experimental group after treatment(P <0.05, P <0.01,P <0.05, respectively).There was no significant differences in FBG in both groups . Conclusion Losartan can reduce hs-CRP and improve insulin resistance in hypertensive patients.